Search for: "B&M MANUFACTURING COMPANY, INC" Results 281 - 300 of 332
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jul 2008, 1:38 am
Botulism is a rare, life-threatening paralytic illness caused by neurotoxins produced by an anaerobic, gram-positive, spore-forming bacterium, Clostridium botulinum. [read post]
6 Aug 2014, 6:36 am by Bill Marler
During this time, FDA launched an investigation of the Bolthouse Farms, Inc., manufacturing plant in Bakersfield, California. [read post]
1 Nov 2008, 3:12 am
(Post Grant Opposition) 'In US, expert witnesses are partisan' article by Adam Liptak (Philip Brooks' Patent Infringement Updates) Seventh Circuit's American Jury Project (Chicago IP Litigation Blog) (Chicago IP Litigation Blog) US General - Decisions Merrill Lunch & Co brokerage arm wins partial injunction against former financial advisor Sharon M Kurgis accused of stealing clients (Law360) US General - Lawsuits and strategic steps American Power… [read post]
10 Oct 2010, 8:11 am by Mandelman
  I’m not bragging, our politicians are nothing if not predictable.) [read post]
23 Mar 2012, 12:42 pm by Pace Law School Library
Preventing coal companies from using compliance schedules to loophole around th [read post]
9 Jun 2018, 9:20 am by Eric Goldman
The court found trademark rights for Viacom “[b]ecause ‘The Krusty Krab’ is a recurring element of the ‘SpongeBob SquarePants’ show. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
  Regardless of how they are counted, the coronavirus-related securities lawsuits tended to fall into one of three categories: first, the lawsuit filed against companies that experienced coronavirus outbreaks within company facilities (such as cruise ship lines and private prison systems); second, companies that had sought to tout their ability to profit from the coronavirus outbreak (such as vaccine developers, diagnostic testing services, … [read post]
16 Jun 2014, 4:45 am by Rebecca Tushnet
McNeil-P.P.C., Inc., 973 F.2d 1033, 1046 (2d Cir. 1992) (house brands can prevent confusion). [read post]
23 Jul 2010, 7:28 am by Bexis
Bradlees of New England, Inc., 250 F.3d 10, 16 (1st Cir. 2001). [read post]
19 Oct 2016, 1:04 pm by Cynthia Marcotte Stamer
§2575.2(m) $1,000 per failure $1,087 per failure   Sponsor of Cooperative and Small Employer Charity (CSEC) plan   Failure to establish or update a funding restoration plan 502(c)(12) $100 per day $100 per day (no change) The civil penalty increase provides yet another reason for employer and other plan sponsors,. fiduciaries and administrators to strive to prevent ERISA violations. [read post]
31 May 2019, 9:47 am by Rebecca Tushnet
I’m just the king of a kingdom that doesn’t brew beer with corn syrup. [read post]
30 Jan 2009, 7:00 pm
(Patent Prospector)   US Patents Congress weighs patent specialisation for federal judges (Ars Technica) (Inventive Step) (Law360) (IP Spotlight) (Patent Prospector) M Lemley & B Sampat’s report ‘Examiner Characteristics and the Patent Grant Rate’ – experienced examiners allow more, cite less (Peter Zura's 271 Patent Blog) PTO problems are not new; the more things change, the more they stay the same (Inventive Step) Peer… [read post]
5 Jul 2012, 12:31 pm by Steven Boutwell
For example, the following endorsement limits both the length of the polluting event and requires written notice within thirty (30) days of the commencement of the event: b. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy:… [read post]